Bank of New York Mellon Corp Cuts Stock Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Bank of New York Mellon Corp lowered its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 6.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,181 shares of the medical instruments supplier's stock after selling 13,653 shares during the quarter. Bank of New York Mellon Corp owned 0.79% of ICU Medical worth $29,821,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. FMR LLC raised its position in ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after buying an additional 100,345 shares during the last quarter. State Street Corp raised its holdings in shares of ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after purchasing an additional 77,506 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of ICU Medical by 9.6% during the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock valued at $99,687,000 after purchasing an additional 48,106 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in ICU Medical by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier's stock valued at $54,868,000 after purchasing an additional 27,927 shares during the period. Finally, Principal Financial Group Inc. boosted its holdings in ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after purchasing an additional 25,031 shares during the last quarter. 96.10% of the stock is owned by institutional investors.

Remove Ads

ICU Medical Stock Performance

ICUI traded up $2.98 during midday trading on Wednesday, reaching $141.97. The company had a trading volume of 196,571 shares, compared to its average volume of 230,542. The business has a 50-day moving average of $158.23 and a two-hundred day moving average of $165.42. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The company has a market cap of $3.48 billion, a P/E ratio of -30.91 and a beta of 0.73.

Insider Buying and Selling

In related news, CEO Vivek Jain sold 1,373 shares of the company's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 6.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp boosted their price target on ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research note on Wednesday, November 13th. Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday. Finally, StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Monday. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, ICU Medical has a consensus rating of "Moderate Buy" and a consensus price target of $168.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.